EU approval for new AI technology that can predict heart attacks
CaRi-Heart technology can identify people at high risk of a fatal heart attack
Read More
Tag: Caristo Diagnostics
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
